Literature DB >> 31445038

Competition for Clinical Trials in Inflammatory Bowel Diseases.

M Scott Harris1, Jolanta Wichary2, Matt Zadnik3, Walter Reinisch4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31445038     DOI： 10.1053/j.gastro.2019.08.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.

Authors:  Bram Verstockt; Nurulamin M Noor; Urko M Marigorta; Polychronis Pavlidis; Parakkal Deepak; Ryan C Ungaro
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

2.  Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.

Authors:  Fares Ayoub; Matthew Odenwald; Dejan Micic; Sushila R Dalal; Joel Pekow; Russell D Cohen; David T Rubin; Atsushi Sakuraba
Journal:  Intest Res       Date:  2022-02-08

3.  Trends and Characteristics of Clinical Trials Participation for Inflammatory Bowel Disease in the United States: A Report From IBD Partners.

Authors:  Cole Johnson; Edward L Barnes; Xian Zhang; Millie D Long
Journal:  Crohns Colitis 360       Date:  2020-04-15

4.  Declining Use of Corticosteroids for Crohn's Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial.

Authors:  M T Balart; L Russell; N Narula; G Bajaj; U Chauhan; K J Khan; A N Marwaha; E Ching; J Biro; S Halder; F Tse; J K Marshall; S M Collins; P Moayyedi; P Bercik; E F Verdu; G I Leontiadis; D Armstrong; M I Pinto-Sanchez
Journal:  J Can Assoc Gastroenterol       Date:  2020-11-20

5.  Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease.

Authors:  Gajanan D Katkar; Ibrahim M Sayed; Mahitha Shree Anandachar; Vanessa Castillo; Eleadah Vidales; Daniel Toobian; Fatima Usmani; Joseph R Sawires; Geoffray Leriche; Jerry Yang; William J Sandborn; Soumita Das; Debashis Sahoo; Pradipta Ghosh
Journal:  Commun Biol       Date:  2022-03-14

6.  JAK Inhibitors: Back to Small Molecules for the Treatment of IBD.

Authors:  Julian Panés; Severine Vermeire
Journal:  J Crohns Colitis       Date:  2020-08-01       Impact factor: 9.071

Review 7.  Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments.

Authors:  Klaus Gottlieb; Marco Daperno; Keith Usiskin; Bruce E Sands; Harris Ahmad; Colin W Howden; William Karnes; Young S Oh; Irene Modesto; Colleen Marano; Ryan William Stidham; Walter Reinisch
Journal:  Gut       Date:  2020-07-22       Impact factor: 23.059

8.  Chrysophanol Attenuates Manifestations of Immune Bowel Diseases by Regulation of Colorectal Cells and T Cells Activation In Vivo.

Authors:  Hyun-Su Lee; Gil-Saeng Jeong
Journal:  Molecules       Date:  2021-03-17       Impact factor: 4.411

9.  Moving towards more patient-centred clinical trials in IBD.

Authors:  Nurulamin M Noor; Miles Parkes; Tim Raine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10       Impact factor: 73.082

Review 10.  Methotrexate in inflammatory bowel disease: A primer for gastroenterologists.

Authors:  Turki AlAmeel; Eman Al Sulais; Tim Raine
Journal:  Saudi J Gastroenterol       Date:  2022 Jul-Aug       Impact factor: 3.214
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.